Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/29/24 17:00 | 11/27/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | 2 | S.d | -935 | 534.93 | 0 | -2 | 9 | D | ||||||||||||||||
9/9/24 16:18 | 9/6/24 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | 1 | S | -235 | 469.37 | 0 | -1 | 6 | I | ||||||||||||||||
5/20/24 17:00 | 5/17/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Claflin Bruce L. | ME | D | 1 | S | -108 | 540.80 | 0 | 0 | 2 | D | ||||||||||||||||
3/7/24 17:00 | 3/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | 2 | S.d | -10,597 | 536.83 | 0 | -20 | 11 | D | |||||||||||||||
2/9/24 17:03 | 2/8/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | 1 | S.d | -4,705 | 573.87 | 0 | -8 | 7 | D | |||||||||||||||
2/9/24 17:01 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | 1 | S.d | -13,296 | 570.01 | 0 | -23 | 48 | D | |||||||||||||||
2/9/24 17:00 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | 2 | S.d | -10,528 | 550.42 | 0 | -19 | 79 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |